Zhongyi Dong

13PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 13, 2026
Assessment of pneumonitis in patients with lung cancer undergoing radioimmunotherapy and immune checkpoint inhibitor rechallenge.

Yingchen Ruan, Minjie Ruan, Zhishen Fang

|Mar 05, 2026
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.

Si-Cong Ma, Zi-Xuan Rong, Zi-Peng Xu

|Nov 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.

Yang-Si Li, Wenpu Lai, Kai Yin

|Mar 27, 2024
Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases.

Jia-Run Lin, Duan-Duan Han, Wei Wei

|Mar 04, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.

Xue Bai, Ze-Qin Guo, Yan-Pei Zhang

|Jan 04, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validation.

Xue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong

Pageof 3

Frequent Collaborators

5 joint publications

Si-Cong Ma

4 joint publications

Yan-Pei Zhang

4 joint publications

Dehua Wu

3 joint publications

Li Liu